SCHEMBL29696017

SCHEMBL29696017

C1=NNCc2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.42
TRPA1 O75762 1/20 0.41
PNMT P11086 1/20 0.32
CD44 P16070 1/20 0.32
MAOB P27338 1/20 0.32
HTR2C P28335 1/20 0.31
CA12 O43570 1/20 0.30
CA9 Q16790 1/20 0.30
ALOX15 P16050 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL213709 1.00 PARP1 (0.42) PARP1TRPA1PNMTCD44MAOB
SCHEMBL6488209 0.98 PARP1 (0.41) PARP1TRPA1PNMTCD44MAOB
SCHEMBL7309901 0.92 PARP1 (0.37) PARP1TRPA1PNMTCD44MAOB
Formic Acid SCHEMBL28778115 0.89 PARP1 (0.35) PARP1TRPA1
SCHEMBL4969401 0.78 HTR2C (0.43) PARP1TRPA1PNMTCD44MAOB
SCHEMBL19540042 0.75 TSHR (0.39) TRPA1PNMTCD44MAOBHTR2C
SCHEMBL5072285 0.71 TRPA1 (0.44) PARP1TRPA1PNMT
SCHEMBL10152893 0.70 PARP1 (0.39) PARP1TRPA1PNMTCD44MAOB
SCHEMBL28067377 0.69 HTR2C (0.34) TRPA1PNMTCD44MAOBHTR2C
SCHEMBL4166260 0.68 PNMT (0.37) PNMTCD44MAOBHTR2CALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119751360-A 1-Amide-1, 2-dihydro phthalazine compound and preparation method and application thereof 河南警察学院 2025-04-04 CN claimed
EP-4628483-A1 DIHYDROPHTHALAZINE-CONTAINING COMPOUND Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2025-10-08 EP disclosed
CN-120712260-A Compound containing dihydro phthalazine and alkenyl and its use 正大天晴药业集团股份有限公司 2025-09-26 CN disclosed
WO-2025113499-A1 COMPOUND CONTAINING HETEROCYCLIC DIHYDROPHTHALAZINE 正大天晴药业集团股份有限公司 2025-06-05 WO disclosed
CN-119874617-A Preparation method of azelastine hydrochloride intermediate 贵州云峰药业有限公司 2025-04-25 CN disclosed
CN-119751360-A 1-Amide-1, 2-dihydro phthalazine compound and preparation method and application thereof 河南警察学院 2025-04-04 CN disclosed
CN-119751360-A 1-Amide-1, 2-dihydro phthalazine compound and preparation method and application thereof 河南警察学院 2025-04-04 CN disclosed
CN-119751360-A 1-Amide-1, 2-dihydro phthalazine compound and preparation method and application thereof 河南警察学院 2025-04-04 CN disclosed
CN-116655591-B 3, 4-Dihydro phthalazine-1 (2H) -ketone derivative and preparation method and application thereof 中国人民解放军军事科学院军事医学研究院 2024-11-08 CN disclosed
CN-116655591-B 3, 4-Dihydro phthalazine-1 (2H) -ketone derivative and preparation method and application thereof 中国人民解放军军事科学院军事医学研究院 2024-11-08 CN disclosed
CN-117586108-A TOLL-like receptor 8 (TLR 8) specific antagonists, methods of making and uses thereof 科罗拉多州立大学董事会法人团体 2024-02-23 CN disclosed
CN-117586191-A TOLL-like receptor 8 (TLR 8) specific antagonists, methods of making and uses thereof 科罗拉多州立大学董事会法人团体 2024-02-23 CN disclosed
CN-111788183-B Heterocyclic fused phenyl compounds useful for inhibiting TNIK and medical uses thereof 韩国化学硏究院 2024-02-23 CN disclosed
CN-114560828-B Polymerizable compound and optically anisotropic body formed therefrom 江苏创拓新材料有限公司 2024-01-26 CN disclosed
CN-111542515-B TOLL-like receptor 8 (TLR 8) specific antagonists, methods of making and uses thereof 科罗拉多州立大学董事会法人团体 2023-12-05 CN disclosed
CN-116655591-A 3, 4-dihydro phthalazine-1 (2H) -ketone derivative and preparation method and application thereof 中国人民解放军军事科学院军事医学研究院 2023-08-29 CN disclosed
CN-116655591-A 3, 4-dihydro phthalazine-1 (2H) -ketone derivative and preparation method and application thereof 中国人民解放军军事科学院军事医学研究院 2023-08-29 CN disclosed
CN-113861128-B Polymerizable compound and optically anisotropic body 江苏创拓新材料有限公司 2023-08-01 CN disclosed
WO-2022138793-A1 COMBINATION BETWEEN EP2 RECEPTOR ANTAGONIST AND IMMUNE CHECKPOINT INHIBITOR AND/OR EP4 RECEPTOR ANTAGONIST 小野薬品工業株式会社 2022-06-30 WO disclosed
WO-2022138791-A1 EP2 ANTAGONIST 小野薬品工業株式会社 2022-06-30 WO disclosed